Approved to treat different types of advanced non–small cell lung cancer (NSCLC) with certain EGFR mutations

Select a type of lung cancer treatment
EGFR+ NSCLC with exon 20 insertion mutations, 1st treatment
Grey next arrow icon
EGFR+ NSCLC with exon 20 insertion mutations, 2nd treatment
Grey next arrow icon
Not sure which of the options above to select?
Ask your doctor and learn more about the types of lung cancer RYBREVANT® is approved to treat.
Learn about the optionsNext arrow icon
A patient story
Meet Jimmy, a real patient treated with RYBREVANT®

Jimmy’s Story

Meet Jimmy, a patient treated with RYBREVANT®. Hear about his experience and why sharing his story is important to him.

Doctor Discussion Guide

Tips and example questions for having a helpful discussion with your doctor.

Download nowArrow pointing downward
RYBREVANT® doctor discussion guide thumbnailRYBREVANT® doctor discussion guide thumbnail

Savings & Support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant® with meRybrevant® with me
EGFR = epidermal growth factor receptor